Mersana Therapeutics, Inc. (MRSN)

Mersana Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	107.75	174.56	128.89	177.95	255.09
Short-Term Investments	26.87	34.52	151.83	-	-
Cash & Short-Term Investments	134.62	209.08	280.71	177.95	255.09
Cash Growth	-35.61%	-25.52%	57.75%	-30.24%	155.63%
Receivables	-	-	30	-	-
Prepaid Expenses	2.28	4.97	8.51	10.95	3.49
Total Current Assets	136.9	214.06	319.22	188.9	258.58
Property, Plant & Equipment	6.78	11.53	14.46	14.86	12.67
Other Long-Term Assets	0.98	0.48	0.66	2.36	2.15
Total Assets	144.66	226.06	334.34	206.11	273.4
Accounts Payable	4.33	7.32	13.95	12.32	8.34
Accrued Expenses	18.96	20.85	43.18	28.72	16.15
Current Portion of Long-Term Debt	12.5	2.08	-	-	-
Current Portion of Leases	3.9	3.4	3.04	2.54	1.53
Current Unearned Revenue	22.17	28.15	30.61	3.94	3.99
Other Current Liabilities	0.59	1.84	0.75	-	-
Total Current Liabilities	62.46	63.64	91.53	47.52	30
Long-Term Debt	10.95	23.15	24.93	24.63	4.98
Long-Term Leases	1.3	5.2	8.78	11.7	10.33
Long-Term Unearned Revenue	79.46	97.17	117.04	-	-
Other Long-Term Liabilities	-	0	-	0.53	-
Total Liabilities	154.17	189.16	242.28	84.37	45.31
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	886.02	863.24	746.89	572.21	508.5
Retained Earnings	-895.55	-826.36	-654.69	-450.48	-280.42
Comprehensive Income & Other	0.01	0.01	-0.15	-	-
Total Common Equity	-9.51	36.9	92.06	121.74	228.09
Shareholders' Equity	-9.51	36.9	92.06	121.74	228.09
Total Liabilities & Equity	144.66	226.06	334.34	206.11	273.4
Total Debt	28.65	33.83	36.75	38.86	16.84
Net Cash (Debt)	105.97	175.25	243.97	139.08	238.26
Net Cash Growth	-39.53%	-28.17%	75.41%	-41.62%	159.92%
Net Cash Per Share	0.86	1.51	2.60	1.97	3.88
Filing Date Shares Outstanding	124.63	121.3	108.03	83.39	69.04
Total Common Shares Outstanding	115.65	120.71	105.14	73.71	68.84
Working Capital	74.45	150.42	227.69	141.38	228.58
Book Value Per Share	-0.08	0.31	0.88	1.65	3.31
Tangible Book Value	-9.51	36.9	92.06	121.74	228.09
Tangible Book Value Per Share	-0.08	0.31	0.88	1.65	3.31
Machinery	10.29	10.7	9.78	7.74	7.48
Leasehold Improvements	2.21	2.21	1.94	1.91	1.89

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q